FGF21 and obesity due to melanocortin 4 receptor deficiency: Numerous studies have uncovered that FGF21 causes considerable pharmacological benefits on metabolic diseases, such as hyperglycemia, insulin resistance, dyslipidemia, and other obesity-related disorders27.